Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy? [5]

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 6, 2003, Pages 663-665

  Jonas, Jost B ^a,c   Söfker, Antje ^a   Hayler, Jochen ^b   Degenring, Robert F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCARBON; SILICONE OIL; TRIAMCINOLONE ACETONIDE;

CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOSURGERY; FOLLOW UP; HUMAN; LASER COAGULATION; LETTER; OPHTHALMOSCOPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA INJURY; RETINA SURGERY; RETINOTOMY; SCLEROTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY;

EID: 0346269192     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1395-3907.2003.0108.x     Document Type: Letter

References (7)

1. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT & Aylward GW (2001): How to prevent proliferate vitreoretinopathy. A prospective study. Ophthalmology 108: 1184-1486.
2. Berger AS, Cheng CK, Pearson PA, Ashton P, Crooks PA, Cynkowski T, Cynkowska G & Jaffe GJ (1996): Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferate vitreoretinopathy. Invest Ophthalmol Vis Sci 37: 2318-2325.
3. Blumenkranz MS, Claflin A & Hajek AS (1984): Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 102: 598-604.
4. Chen EP, Steinhorst UH, Samsa GP, Saloupis PT & Hatchell DL (1992): The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferate vitreoretinopathy. Invest Ophthalmol Vis Sci 33: 2160-2164.
5. Jonas JB, Hayler JK & Panda-Jonas S (2000): Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferate vitreoretinopathy. Br J Ophthalmol 84: 1064-1067.
6. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S & Degenring R (2003): Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br J Ophthalmol 87: 462-468.
7. Machemer R, Sugita G & Tano Y (1979): Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77: 171-180.